This assay is an enzyme immunoassay intended for the quantitative determination of free retinol-binding protein RBP/RBP4 as well as RBP4 complexed with transthyretin in plasma, serum and…
This assay is an enzyme immunoassay intended for the quantitative determination of free retinol-binding protein RBP/RBP4 as well as RBP4 complexed with transthyretin in plasma, serum and urine
Who Else Makes It
Concentrated in Jilin (1), Shandong (1), Hebei (1).
Record
Regulatory record for Retinol binding Protein (RBP)/RBP4 Elisa | Listed by | DRG Instruments Gesellschaft mit beschränkter Haftung |
| FDA product code | CZS |
| Device type | Retinol-Binding Protein, Antigen, Antiserum, Control |
| Device class | Class 1 |
| Regulation | 21 CFR 866.5765 |
| Premarket notification | Exempt |
| Record published | 2023-08-31 |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Single use | Yes |
| Prescription | Prescription only |
| Supplied as a kit | Yes |
| Label carries | lot or batch number, expiry date, manufacturing date |
| Storage | Storage environment temperature 2 to 8 °C |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.